Inhibition of the Production of Anti-OspA Borreliacidal Antibody with T Cells from Hamsters Vaccinated against Borrelia burgdorferi

Infection and Immunity

Volumn 66, Issue 4, 1998, Pages 1507-1512

  Jensen, Jani R ^a,b,c   Du Chateau, Brian K ^a,b   Munson, Erik L ^a,b   Callister, Steven M ^c   Schell, Ronald F ^a,b  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; LIPOPROTEIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A; RECOMBINANT VACCINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BORRELIA BURGDORFERI; HAMSTER; IMMUNOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; CRICETINAE; LIPOPROTEINS; T-LYMPHOCYTES; VACCINATION; VACCINES, SYNTHETIC;

EID: 0032037782     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.4.1507-1512.1998     Document Type: Article

References (50)

1. Aberer, E., C. Brunner, G. Suchanek, H. Klade, A. Barbour, G. Stanek, and H. Lassmann. 1989. Molecular mimicry and Lyme borreliosis: shared antigenie determinant between Borrelia burgdorferi and human tissue. Ann. Neurol. 26:732-737.
2. Asbrink, E., and A. Hovmark. 1988. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann. N. Y. Acad. Sci. 539:4-15.
3. Aydintug, M. K., Y. Gu, and M. T. Philipp. 1994. Borrelia burgdorferi antigens that are targets of antibody-dependent, complement-mediated killing in the rhesus monkey. Infect. Immun. 62:4929-4937.
4. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525.
5. Burgdorfer, W., R. S. Lane, A. G. Barbour, R. A. Gresbrink, and J. R. Anderson. 1985. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 34:925-930.
6. Callister, S. M., K. L. Case, W. A. Agger, R. F. Schell, R. C. Johnson, and J. L. E. Ellingson. 1990. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J. Clin. Microbiol. 28:363-365.
7. Callister, S. M., and R. F. Schell. 1994. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J. Infect. Dis. 170:499.
8. Callister, S. M., R. F. Schell, K. L. Case, S. D. Lovrich, and S. P. Day. 1993. Characterization of the borreliacidal antibody response in humans: a serodiagnostic test. J. Infect. Dis. 167:158-164.
9. Centers for Disease Control and Prevention. 1997. Lyme disease - United States. 1996. Morbid. Mortal. Weekly Rep. 45:1132-1136.
10. Creson, J. R., L. C. L. Lim, N. J. Glowacki, S. M. Callister, and R. F. Schell. 1996. Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent antibody assay performed by flow cytometry, and Western immunoblotting. Clin. Diagn. Lab. Immunol. 3:184-190.
11. Du Chateau, B. K., J. R. Jensen, D. E. England, S. M. Callister, S. D. Lovrich, and R. F. Schell. 1997. Macrophages and T lymphocytes interact synergistically for the induction of severe destructive Lyme arthritis. Infect. Immun. 65:2829-2836.
12. Dunne, M., B. K. Al-Ramadi, S. W. Barthold, R. A. Flavell, and E. Fikrig. 1995. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect. Immun. 63:1611-1614.
13. Fikrig, E., S. W. Barthold, F. S. Kantor, and R. A. Flavell. 1990. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250:553-556.
14. Fikrig, E., S. W. Barthold, N. Marcantonio, K. Deponte, F. S. Kantor, and R. A. Flavell. 1992. Role of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60:657-661.
15. Foley, D. M., Y. Wang, X. Wu, D. R. Blanco, M. A. Lovett, and J. N. Miller. 1997. Acquired resistance to Borrelia burgdorferi infection in the rabbit: comparison between outer surface protein A vaccine- and infection-derived immunity. J. Clin. Invest. 99:2030-2035.
16. Garcia-Monco, J. C., J. L. Coleman, and J. L. Benach. 1988. Antibodies to myelin basic protein in Lyme disease patients. J. Infect. Dis. 158:667-668.
17. Gilmore, R. D., Jr., K. J. Kappel, M. C. Dolan, T. R. Burkot, and B. J. B. Johnson. 1996. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect. Immun. 64:2234-2239.
18. Jobe, D. A., S. M. Callister, L. C. L. Lim, S. D. Lovrich, and R. F. Schell. 1994. Ability of a canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi. J. Clin. Microbiol. 32:618-622.
19. Johnson, R. C., C. Kodner, and M. Russell. 1986. Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect. Immun. 53:713-714.
20. Kazmierczak, J. J., and F. A. Sorhage. 1993. Current understanding of Borrelia burgdorferi infection, with emphasis on its prevention in dogs. J. Am. Vet. Med. Assoc. 203:1524-1528.
21. Keller, D., F. T. Koster, D. H. Marks, P. Hosbach, L. F. Erdile, and J. P. Mays. 1994. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JAMA 271:1764-1768.
22. Lim, L. C. L., D. M. England, B. K. Du Chateau, N. J. Glowacki, J. R. Creson, S. D. Lovrich, S. M. Callister, D. A. Jobe, and R. F. Schell. 1994. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect. Immun. 62:2825-2833.
23. Lim, L. C. L., D. M. England, B. K. Du Chateau, N. J. Glowacki, and R. F. Schell. 1995. Borrelia burgdorferi specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63:1400-1408.
24. Lim, L. C. L., Y. F. Liu, S. D. Lovrich, S. M. Callister, and R. F. Schell. 1994. Detection of borreliacidal antibody by using acridine orange and flow cytometry. Clin. Diagn. Lab. Immunol. 1:44-50.
25. + T-cell subsets in resistance against infection with Treponema pallidum subsp. pertenue in hamsters. Infect. Immun. 59:529-536.
26. Liu, H., B. M. Steiner, J. D. Alder, D. K. Baertschy, and R. F. Schell. 1990. Immune T cells sorted by flow cytometry confer protection against infection with Treponema pallidum subsp. pertenue in hamsters. Infect. Immun. 58: 1685-1690.
27. Logigian, E. L., R. F. Kaplan, and A. C. Steere. 1990. Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med. 321:1438-1444.
28. Lovrich, S. D., S. M. Callister, B. K. Du Chateau, L. C. L. Lim, J. Winfrey, S. P. Day, and R. F. Schell. 1995. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect. Immun. 63:2113-2119.
29. Ma, J., P. M. Gingrich-Baker, P. M. Franchi, P. Bulger, and R. T. Coughlin. 1995. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi. Infect. Immun. 63:2221-2227.
30. Moskophidis, M., and B. Luther. 1993. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi. Zentbl. Mikrobiol. 279:201-213.
31. Ozato, K., N. Mayer, and D. H. Saches. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533-540.
32. Padilla, M. L., S. M. Callister, R. F. Schell, G. L. Bryant, D. A. Jobe, S. D. Lovrich, B. K. Du Chateau, and J. R. Jensen. 1996. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J. Infect. Dis. 174:739-746.
33. Preac-Mursic, V., B. Wilske, E. Patsouris, S. Jauris, G. Will, E. Soutschek, S. Rainhardt, G. Lehnert, U. Klockman, and P. Mehraein. 1992. Active immunization with pC protein of Borrelia burgdorferi infection. Infection 20:342-349.
34. Probert, W. S., and R. B. LeFebvre. 1994. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen. Infect. Immun. 62:1920-1926.
35. Sambri, V., S. Armati, and R. Cevinini. 1993. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement. FEMS Immunol. Med. Microbiol. 7:67-72.
36. Schmitz, J. L., R. F. Schell, S. D. Lovrich, S. M. Callister, and J. E. Coe. 1991. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect. Immun. 59:1916-1921.
37. Schutzer, S. E., J. Luan, and P. K. Coyle. 1997. Detection of Lyme disease after Osp A vaccine. N. Engl. J. Med. 337:794-795.
38. Scriba, M., J. S. Ebrahim, T. Schlott, and H. Eiffert. 1993. The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies. Infect. Immun. 61:4523-4526.
39. Sigal, L. H. 1993. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J. Infect. Dis. 167:1372-1378.
40. Simon, M. M., U. E. Schaible, M. D. Kramer, C. Eckerskorn, C. Museteanu, H. K. Muller-Hermelink, and R. Wallich. 1991. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164:123-132.
41. Steere, A. C. 1989. Lyme disease. N. Engl. J. Med. 321:586-596.
42. Steere, A. C., N. H. Bartenhagen, J. E. Craft, G. J. Hutchinson, J. H. Newman, D. W. Rahn, L. H. Sigal, P. H. Spieler, K. S. Stenn, and S. E. Malawista. 1983. The early clinical manifestations of Lyme disease. Ann. Intern. Med. 99:76-82.
43. Steere, A. C., W. P. Batsford, M. Weinberg, J. Alexander, H. J. Berger, S. Wolfson, and S. E. Malawista. 1980. Lyme carditis: cardiac abnormalities of Lyme disease. Ann. Intern. Med. 93:8-16.
44. Steere, A. C., and S. E. Malawista. 1979. Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann. Intern. Med. 91:730-733.
45. Steere, A. C., S. E. Malawista, D. R. Snydman, R. E. Shope, W. A. Andiman, M. R. Ross, and F. M. Steele. 1977. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20:7-17.
46. Steere, A. C., R. T. Schoen, and E. Taylor. 1987. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107:725-731.
47. Stover, C. K., G. P. Bansal, M. S. Hanson, J. E. Burlein, S. R. Palaszynski, J. F. Young, S. Koenig, D. B. Young, A. Sadziene, and A. G. Barbour. 1993. Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178:197-209.
48. Straubinger, R. K., Y. Chang, R. H. Johnson, and M. J. G. Appel. 1995. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J. Clin. Microbiol. 33:2745-2751.
49. Witte, P. L., J. Stein-Streilein, and J. W. Streilein. 1985. Description of phenotypically distinct T-lymphocyte subsets which mediate helper/DTH and cytotoxic functions in the Syrian hamster. J. Immunol. 134:2908-2915.
50. Witte, P. L., and J. W. Streilein. 1983. Monoclonal antibodies to hamster class II MHC molecules distinguish T and B cells. J. Immunol. 130:2282-2286.